Manuela Zereu

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial

Martin Schüler, James Chih‐Hsin Yang, K. Park et al. · Annals of Oncology · 2015 · 132 citations · Full text

Medicine, Oncology, Pharmacology +13

A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer

M.H. Cullen, Petr Zatloukal, S Sörenson et al. · Annals of Oncology · 2008 · 73 citations

Medicine, Oncology, Pharmacology +14

PF-06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin®), Both Plus Paclitaxel and Carboplatin, as First-Line Treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Study

Niels Reinmuth, Maciej Bryl, Igor Bondarenko et al. · BioDrugs · 2019 · 56 citations · Full text

Medicine, Oncology, Pharmacology +13

Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09)

Nizar M. Tannir, Maria Nirvana Formiga, Konstantin Penkov et al. · Journal of Clinical Oncology · 2024 · 24 citations

Medicine, Immunology, Oncology +17

Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix

Manuela Zereu, Cláudio Galleano Zettler, Eduardo Cambruzzi et al. · Gynecologic Oncology · 2006 · 22 citations

Medicine, Microbiology, Pathology +11